Your browser doesn't support javascript.
loading
Specific Antileukemic Activity of PD0332991, a CDK4/6 Inhibitor, against Philadelphia Chromosome-Positive Lymphoid Leukemia.
Nemoto, Atsushi; Saida, Satoshi; Kato, Itaru; Kikuchi, Jiro; Furukawa, Yusuke; Maeda, Yasuhiro; Akahane, Koshi; Honna-Oshiro, Hiroko; Goi, Kumiko; Kagami, Keiko; Kimura, Shinya; Sato, Yuko; Okabe, Seiichi; Niwa, Akira; Watanabe, Kenichiro; Nakahata, Tatsutoshi; Heike, Toshio; Sugita, Kanji; Inukai, Takeshi.
Afiliação
  • Nemoto A; Department of Pediatrics, School of Medicine, University of Yamanashi, Yamanashi, Japan.
  • Saida S; Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Kato I; Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Kikuchi J; Stem Cell Regulation, Center for Molecular Medicine, Jichi Medical School, Tochigi, Japan.
  • Furukawa Y; Stem Cell Regulation, Center for Molecular Medicine, Jichi Medical School, Tochigi, Japan.
  • Maeda Y; Department of Hematology, National Hospital Organization, Osaka Minami Medical Center, Osaka, Japan.
  • Akahane K; Department of Pediatrics, School of Medicine, University of Yamanashi, Yamanashi, Japan.
  • Honna-Oshiro H; Department of Pediatrics, School of Medicine, University of Yamanashi, Yamanashi, Japan.
  • Goi K; Department of Pediatrics, School of Medicine, University of Yamanashi, Yamanashi, Japan.
  • Kagami K; Department of Pediatrics, School of Medicine, University of Yamanashi, Yamanashi, Japan.
  • Kimura S; Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga, Japan.
  • Sato Y; Adult Nursing, The Japanese Red Cross College of Nursing, Tokyo, Japan.
  • Okabe S; Department of Hematology, Tokyo Medical University, Tokyo, Japan.
  • Niwa A; Department of Clinical Application, Center for iPS Cell Research and Application, Kyoto University, Kyoto, Japan.
  • Watanabe K; Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Nakahata T; Department of Clinical Application, Center for iPS Cell Research and Application, Kyoto University, Kyoto, Japan.
  • Heike T; Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Sugita K; Department of Pediatrics, School of Medicine, University of Yamanashi, Yamanashi, Japan.
  • Inukai T; Department of Pediatrics, School of Medicine, University of Yamanashi, Yamanashi, Japan. tinukai@yamanashi.ac.jp.
Mol Cancer Ther ; 15(1): 94-105, 2016 Jan.
Article em En | MEDLINE | ID: mdl-26637365
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piperazinas / Piridinas / Inibidores de Proteínas Quinases / Quinase 4 Dependente de Ciclina / Quinase 6 Dependente de Ciclina / Antineoplásicos Limite: Animals / Humans Idioma: En Revista: Mol Cancer Ther Assunto da revista: ANTINEOPLASICOS Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Japão País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piperazinas / Piridinas / Inibidores de Proteínas Quinases / Quinase 4 Dependente de Ciclina / Quinase 6 Dependente de Ciclina / Antineoplásicos Limite: Animals / Humans Idioma: En Revista: Mol Cancer Ther Assunto da revista: ANTINEOPLASICOS Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Japão País de publicação: Estados Unidos